Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd > If value and blig

<< Previous

Bullboard Posts

Next >>

Comment by threefiftynineon Jun 25, 2020 5:23pm

48 Views

Post# 31192568

RE:RE:If value and blig

A lot of explaining to do ---started off with a website down for weeks with no explanation and then botched news releases- and now silence for weeks and weeks on preclinical trials---time for the big boys to step in and take a forensic peek at this fiasco---BUT WAIT-----still 6.5 hours left on or about the 25th ---My laser dinghy may have to wait another few days to be launched it seems

<< Previous

Bullboard Posts

Next >>

Fortuna reports record earnings for Q3 2024